by Konstantina Zafeiropoulou
Following the GMFH 2022 Year at a Glance report, it is time for a flashback in the latest research on cancer microbiome. This post ranges between the epidemiology, etiology and diagnosis of cancer, looking at the role of fungal and bacterial gut microbiome in all three health care branches.
by Andreu Prados
A new study has found that exposure to triclosan increases colonic inflammation and colitis-associated colon tumorigenesis in mice.
by Andreu Prados
This is the first study that characterizes relationships between gut microbial communities and miRNA expression in human CRC tissues.
by Andreu Prados
A review by Dr. Christian Jobin discusses how cancer immunotherapies could be used with more precision when considering gut microbiota-mediated interactions with the immune system.
by Cristina Sáez
During the BDebate conference, Núria Malats, a researcher at the Spanish National Cancer Research Centre (CNIO), answered questions about gut microbiota’s influence on drug efficacy.
In the past decades, some studies have shed light on the importance of diet in reducing the risk of cancer.
by GMFH Editing Team
During the 5th Gut Microbiota for Health World Summit 2016, held in Miami, we had the opportunity to talk to Francisco Guarner.
